Kang EM - Search Results

1

Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is established.

Kang EM, Zickler PP, Burns S, Langemeijer SM, Brenner S, Phang OA, Patterson N, Harlan D, Tisdale JF. Kang EM, et al. Exp Hematol. 2005 Jun;33(6):699-705. doi: 10.1016/j.exphem.2005.03.008. Exp Hematol. 2005. PMID: 15911094 Free article.

2

Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation.

Kang EM, Hanazano Y, Frare P, Vanin EF, De Witte M, Metzger M, Liu JM, Tisdale JF. Kang EM, et al. Mol Ther. 2001 Jun;3(6):911-9. doi: 10.1006/mthe.2001.0337. Mol Ther. 2001. PMID: 11407905 Free article.

3

Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome.

Kang EM, de Witte M, Malech H, Morgan RA, Phang S, Carter C, Leitman SF, Childs R, Barrett AJ, Little R, Tisdale JF. Kang EM, et al. Blood. 2002 Jan 15;99(2):698-701. doi: 10.1182/blood.v99.2.698. Blood. 2002. PMID: 11781257 Free article.

4

Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait.

Kang EM, Areman EM, David-Ocampo V, Fitzhugh C, Link ME, Read EJ, Leitman SF, Rodgers GP, Tisdale JF. Kang EM, et al. Blood. 2002 Feb 1;99(3):850-5. doi: 10.1182/blood.v99.3.850. Blood. 2002. PMID: 11806986 Free article. Clinical Trial.

5

Gene therapy-based treatment for HIV-positive patients with malignancies.

Kang EM, De Witte M, Malech H, Morgan RA, Carter C, Leitman SF, Childs R, Barrett AJ, Little R, Tisdale JF. Kang EM, et al. J Hematother Stem Cell Res. 2002 Oct;11(5):809-16. doi: 10.1089/152581602760404612. J Hematother Stem Cell Res. 2002. PMID: 12427287

6

Retrovirally transduced muscle-derived cells contribute to hematopoiesis at very low levels in the nonhuman primate model.

Gao C, Kang EM, Kuramoto K, Agricola BA, Metzger M, von Kalle C, Donahue RE, Tisdale JF. Gao C, et al. Among authors: kang em. Mol Ther. 2003 Dec;8(6):974-80. doi: 10.1016/j.ymthe.2003.08.017. Mol Ther. 2003. PMID: 14664800 Free article.

7

The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.

Kang EM, Tisdale JF. Kang EM, et al. Curr Hematol Rep. 2004 Jul;3(4):274-81. Curr Hematol Rep. 2004. PMID: 15217557 Review.

8

Cloning and functional analysis of the rhesus macaque ABCG2 gene. Forced expression confers an SP phenotype among hematopoietic stem cell progeny in vivo.

Ueda T, Brenner S, Malech HL, Langemeijer SM, Perl S, Kirby M, Phang OA, Krouse AE, Donahue RE, Kang EM, Tisdale JF. Ueda T, et al. Among authors: kang em. J Biol Chem. 2005 Jan 14;280(2):991-8. doi: 10.1074/jbc.M409796200. Epub 2004 Oct 30. J Biol Chem. 2005. PMID: 15516692 Free article.

9

Low-dose radiation plus rapamycin promotes long-term bone marrow chimerism.

Powell JD, Fitzhugh C, Kang EM, Hsieh M, Schwartz RH, Tisdale JF. Powell JD, et al. Among authors: kang em. Transplantation. 2005 Dec 15;80(11):1541-5. doi: 10.1097/01.tp.0000185299.72295.90. Transplantation. 2005. PMID: 16371922

10

Busulfan pharmacokinetics, toxicity, and low-dose conditioning for autologous transplantation of genetically modified hematopoietic stem cells in the rhesus macaque model.

Kang EM, Hsieh MM, Metzger M, Krouse A, Donahue RE, Sadelain M, Tisdale JF. Kang EM, et al. Exp Hematol. 2006 Feb;34(2):132-9. doi: 10.1016/j.exphem.2005.10.010. Exp Hematol. 2006. PMID: 16459181 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters